Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 4
1992 2
1993 2
1996 1
1997 3
1998 3
2000 1
2002 2
2003 1
2004 2
2005 2
2006 3
2007 2
2008 4
2009 5
2010 8
2011 17
2012 7
2013 6
2014 4
2015 6
2016 7
2017 5
2018 2
2019 10
2020 14
2021 10
2022 7
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for hanggi tu
Search for Hangdi Tu instead (1 results)
Cell death, therapeutics, and the immune response in cancer.
Hänggi K, Ruffell B. Hänggi K, et al. Trends Cancer. 2023 May;9(5):381-396. doi: 10.1016/j.trecan.2023.02.001. Epub 2023 Feb 24. Trends Cancer. 2023. PMID: 36841748 Review.
Induction of cell death is inexorably linked with cancer therapy, but this can also initiate wound-healing processes that have been linked to cancer progression and therapeutic resistance. Here we describe the contribution of apoptosis and the lytic cell death pathways in …
Induction of cell death is inexorably linked with cancer therapy, but this can also initiate wound-healing processes that have been linked t …
Nimodipine Reappraised: An Old Drug With a Future.
Carlson AP, Hänggi D, Macdonald RL, Shuttleworth CW. Carlson AP, et al. Curr Neuropharmacol. 2020;18(1):65-82. doi: 10.2174/1570159X17666190927113021. Curr Neuropharmacol. 2020. PMID: 31560289 Free PMC article. Review.
Newer understanding of the pathophysiology of delayed ischemic injury after a variety of acute neurologic injuries including aSAH, traumatic brain injury (TBI) and ischemic stroke, coupled with advances in the drug delivery method for nimodipine, have reignited interest in refini …
Newer understanding of the pathophysiology of delayed ischemic injury after a variety of acute neurologic injuries including aSAH, traumatic …
Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers.
Biswas S, Mandal G, Anadon CM, Chaurio RA, Lopez-Bailon LU, Nagy MZ, Mine JA, Hänggi K, Sprenger KB, Innamarato P, Harro CM, Powers JJ, Johnson J, Fang B, Eysha M, Nan X, Li R, Perez BA, Curiel TJ, Yu X, Rodriguez PC, Conejo-Garcia JR. Biswas S, et al. Immunity. 2023 Nov 14;56(11):2570-2583.e6. doi: 10.1016/j.immuni.2023.09.013. Epub 2023 Oct 30. Immunity. 2023. PMID: 37909039 Free article.
Unruptured Intracranial Aneurysms.
Hackenberg KAM, Hänggi D, Etminan N. Hackenberg KAM, et al. Stroke. 2018 Sep;49(9):2268-2275. doi: 10.1161/STROKEAHA.118.021030. Stroke. 2018. PMID: 30355003 Review. No abstract available.
The Immune Microenvironment and Cancer Metastasis.
El-Kenawi A, Hänggi K, Ruffell B. El-Kenawi A, et al. Cold Spring Harb Perspect Med. 2020 Apr 1;10(4):a037424. doi: 10.1101/cshperspect.a037424. Cold Spring Harb Perspect Med. 2020. PMID: 31501262 Free PMC article. Review.
Understanding how disseminated tumor cells evade and corrupt the immune system during the final stages of metastasis will be pivotal in developing new therapeutic modalities that combat metastasis....
Understanding how disseminated tumor cells evade and corrupt the immune system during the final stages of metastasis will be pivotal in deve …
Effect of Early Sustained Prophylactic Hypothermia on Neurologic Outcomes Among Patients With Severe Traumatic Brain Injury: The POLAR Randomized Clinical Trial.
Cooper DJ, Nichol AD, Bailey M, Bernard S, Cameron PA, Pili-Floury S, Forbes A, Gantner D, Higgins AM, Huet O, Kasza J, Murray L, Newby L, Presneill JJ, Rashford S, Rosenfeld JV, Stephenson M, Vallance S, Varma D, Webb SAR, Trapani T, McArthur C; POLAR Trial Investigators and the ANZICS Clinical Trials Group. Cooper DJ, et al. JAMA. 2018 Dec 4;320(21):2211-2220. doi: 10.1001/jama.2018.17075. JAMA. 2018. PMID: 30357266 Free PMC article. Clinical Trial.
Grading of lung adenocarcinomas with simultaneous segmentation by artificial intelligence (GLASS-AI).
Lockhart JH, Ackerman HD, Lee K, Abdalah M, Davis AJ, Hackel N, Boyle TA, Saller J, Keske A, Hänggi K, Ruffell B, Stringfield O, Cress WD, Tan AC, Flores ER. Lockhart JH, et al. NPJ Precis Oncol. 2023 Jul 18;7(1):68. doi: 10.1038/s41698-023-00419-3. NPJ Precis Oncol. 2023. PMID: 37464050 Free PMC article.
Preclinical genetically engineered mouse models (GEMMs) of lung adenocarcinoma are invaluable for investigating molecular drivers of tumor formation, progression, and therapeutic resistance. However, histological analysis of these GEMMs requires significant time and traini …
Preclinical genetically engineered mouse models (GEMMs) of lung adenocarcinoma are invaluable for investigating molecular drivers of tumor f …
Rebleeding after aneurysmal subarachnoid hemorrhage.
Starke RM, Connolly ES Jr; Participants in the International Multi-Disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Starke RM, et al. Neurocrit Care. 2011 Sep;15(2):241-6. doi: 10.1007/s12028-011-9581-0. Neurocrit Care. 2011. PMID: 21761274 Review.
Overall, studies investigating antifibrinolytic therapy to reduce rebleeding have failed to clearly demonstrate overall therapeutic benefit. Short-course antifibrinolytic therapy may have a role prior to initial aneurysm repair, although insufficient data are currently ava …
Overall, studies investigating antifibrinolytic therapy to reduce rebleeding have failed to clearly demonstrate overall therapeutic b …
130 results